Immunocore Holdings (IMCR) Payables (2022 - 2025)
Historic Payables for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $23.0 million.
- Immunocore Holdings' Payables fell 6620.54% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year decrease of 6620.54%. This contributed to the annual value of $25.1 million for FY2024, which is 4102.71% up from last year.
- According to the latest figures from Q3 2025, Immunocore Holdings' Payables is $23.0 million, which was down 6620.54% from $23.9 million recorded in Q2 2025.
- Immunocore Holdings' Payables' 5-year high stood at $67.9 million during Q3 2024, with a 5-year trough of $14.4 million in Q4 2022.
- Over the past 4 years, Immunocore Holdings' median Payables value was $23.0 million (recorded in 2025), while the average stood at $26.3 million.
- Examining YoY changes over the last 5 years, Immunocore Holdings' Payables showed a top increase of 8776.21% in 2025 and a maximum decrease of 6620.54% in 2025.
- Immunocore Holdings' Payables (Quarter) stood at $14.4 million in 2022, then rose by 23.17% to $17.8 million in 2023, then skyrocketed by 41.03% to $25.1 million in 2024, then decreased by 8.54% to $23.0 million in 2025.
- Its Payables was $23.0 million in Q3 2025, compared to $23.9 million in Q2 2025 and $29.1 million in Q1 2025.